(Reuters) – Drug distributor AmerisourceBergen Corp and asset management firm TPG Inc said on Thursday they have agreed to buy OneOncology from General Atlantic in a deal valued at $2.1 billion.
TPG will buy a majority interest in OneOncology, while AmerisourceBergen will purchase a minority stake for around $685 million in cash.
OneOncology is a partnership of U.S. cancer practitioners with more than 900 affiliated providers.
The deal is expected to contribute a few cents to AmerisourceBergen’s adjusted profit in the first year post close.
(Reporting by Raghav Mahobe in Bengaluru; Editing by Devika Syamnath)
